Associate Sponsors

Co-sponsor

Sales decline 94.31% to Rs 0.57 crore

Net Loss of Surya Pharmaceutical reported to Rs 867.83 crore in the quarter ended December 2013 as against net loss of Rs 77.94 crore during the previous quarter ended December 2012. Sales declined 94.31% to Rs 0.57 crore in the quarter ended December 2013 as against Rs 10.02 crore during the previous quarter ended December 2012. ParticularsQuarter EndedDec. 2013Dec. 2012% Var.Sales0.5710.02 -94 OPM %-108256.14-88.32 -PBDT-632.99-67.74 -834 PBT-648.66-77.94 -732 NP-867.83-77.94 -1013

Powered by Capital Market - Live News

More From This Section

First Published: Feb 15 2014 | 6:15 PM IST

Next Story